US Stock MarketDetailed Quotes

GRFS Grifols

Watchlist
  • 7.510
  • -0.210-2.72%
Close Dec 20 16:00 ET
  • 7.510
  • 0.0000.00%
Post 20:01 ET
5.10BMarket Cap30.16P/E (TTM)

About Grifols Company

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Company Profile

SymbolGRFS
Company NameGrifols
Listing DateJun 2, 2011
Founded1940
CEOMr. Jose Ignacio Abia Buenache
MarketNASDAQ
Employees23744
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressAvinguda de la Generalitat, 152-158,Parc de Negocis Can Sant Joan,Sant Cugat del Vallès
CityBarcelona
ProvinceCatalonia
CountrySpain
Zip Code08174
Phone34-93-571-02-21
Websitehttp://www.grifols.com

Company Executives

  • Name
  • Position
  • Salary
  • Jose Ignacio Abia Buenache
  • Director and Chief Executive Officer
  • --
  • Camille Alpi
  • Chief Human Resources and Talent Officer
  • --
  • Víctor Grifols Deu
  • Director and Chief Operating Officer
  • --
  • Maria Teresa Rione Llano
  • Chief Communications Officer
  • --
  • Raimon Grifols Roura
  • Vice Chairman of the Board and Chief Corporate Officer
  • --
  • Daniel Fleta Coit
  • Chief Industrial Services Officer
  • --
  • Alfredo Arroyo Guerra
  • Chief Financial Officer
  • --
  • Dr. Jorg Schuttrumpf
  • Chief Scientific Innovation Officer
  • --
  • David Ian Bell
  • General Counsel, Chief Corporate Development, Legal and Data Protection Officer
  • --
  • Miguel Louzan
  • Chief Digital Information Officer
  • --
  • Ignacio Ramal Subira
  • Chief Internal Audit and Enterprise Risk Manager
  • --
  • Lluis Pons Gomez
  • Senior Vice President, Strategy and COO Office
  • --
  • Francisco Javier Guix Huguet
  • Vice President, Healthcare Solutions
  • --
  • Laura Carratala Pena
  • Vice President, Bio Supplies
  • --
  • Dr. Antonio Martinez Martinez
  • President, Diagnostic Business Unit
  • --
  • Jordi Balsells Valls
  • President, Plasma Procurement
  • --
  • Dr. Roland Wandeler, PhD
  • President, Biopharma Business Unit
  • --
  • Thomas H. Glanzmann
  • Executive Chairman of the Board
  • --
  • Tomas Daga Gelabert
  • Director and Vice Secretary of the Board
  • --
  • Albert Grifols Coma-Cros
  • Director
  • --
  • Susana Gonzalez Rodriguez
  • Independent Director
  • --
  • James Costos
  • Independent Director
  • --
  • Carina Szpilka Lazaro
  • Lead Independent Director
  • --
  • Inigo Sanchez-Asiain Mardones
  • Independent Director
  • --
  • Montserrat Munoz Abellana
  • Independent Director
  • --
  • Enriqueta Felip Font
  • Independent Director
  • --
  • Nuria Martin Barnes
  • Secretary
  • --
  • Laura de la Cruz Galan
  • Vice Secretary
  • --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List